October 9, 2012
Zeria Pharmaceutical said on October 5 that it has terminated the development of the allergic rhinitis treatment Z-207, a project commissioned by the state-backed Japan Science and Technology Agency (JST). The company made the decision based on the JST’s assessment...read more